Anemo Labs

United Kingdom · Healthtech · AI

Anemo Labs is developing an electronic nose that combines proprietary sensors with AI to detect disease-related signals in bodily fluids for non-invasive health screening.

Product and customers

Anemo Labs is developing an electronic nose that combines proprietary sensors with AI to detect disease-related signals in bodily fluids for non-invasive health screening.

Its olfactory chip is designed to detect multiple volatile organic compounds in parallel. The current work targets biomarker screening in urine, sweat and other bodily fluids; the company describes the technology as being in development.

Funding history

1 round · 1 with disclosed amounts
AnnouncedRoundAmountInvestors
Pre-seed£700KSFC Capital — LeadZinc — Lead
Sourcesanemolabs.com ↗